Closed Funding Opportunities

Reset
Download Results Save this Search
NOFO # NOFO Title Research Focus Area Research Program
PA-18-055 Behavioral & Integrative Treatment Development Program (R01 Clinical Trial Optional) Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose
no summary
PA-18-489 NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed) Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose
no summary
PA-18-344 NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose
no summary
PA-18-484 NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose
no summary
PA-18-345 NIH Research Project Grant (Parent R01 Clinical Trial Required) Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose
no summary
PA-18-058 Prescription Drug Abuse (R01 Clinical Trial Optional) Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose
no summary
PAR-18-219 Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional) Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose
no summary
PAR-18-218 Strategic Alliances for Medications Development to Treat Substance Use Disorders (R01 Clinical Trial Optional) Novel Therapeutic Options for Opioid Use Disorder and Overdose Research program not yet identified. Learn about the research led by the NIH Institutes and Centers that are part of the initiative.
no summary
RFA-HL-20-031 HEAL Initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development (R61/R33 - Clinical Trial Not Allowed) Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose
no summary
PAR-20-092 Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional) Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose
no summary
RFA-DA-18-020 NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3 Clinical Trial Optional) Novel Therapeutic Options for Opioid Use Disorder and Overdose Research program not yet identified. Learn about the research led by the NIH Institutes and Centers that are part of the initiative.
no summary
RFA-DA-22-031 HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed) Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose
no summary
RFA-DA-22-032 HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed) Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose
no summary
NOT-DA-21-066 Notice of Correction to RFA-DA-22-031, HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed) Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose
no summary
NOT-DA-21-067 Notice of Correction to RFA-DA-22-032, HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed) Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose
no summary
RFA-HL-22-013 HEAL initiative: Pharmacotherapies to Reverse Opioid Overdose Induced Respiratory Depression Without Central Opioid Withdrawal (Target Validation and Candidate Therapeutic Development) (UG3/UH3 Clinical Trials Not Allowed) Novel Therapeutic Options for Opioid Use Disorder and Overdose Focusing Medication Development to Prevent and Treat Opioid Use Disorder and Overdose
no summary